Literature DB >> 1083675

A characterization of human tonsillar lymphocytes after separation from other tonsillar cells in an isokinetic gradient of ficoll in tissue culture medium.

J K Willson, J L Zaremba, A M Pitts, T G Pretlow.   

Abstract

Purified human tonsillar lymphocytes responded less to mitogentic stimulation than did unseparated tonsillar cells. Their response to mitogens was restored when they were combined with cells from all other gradient fractions. We interpret our data as evidence that the majority of tonsillar lymphocytes require the presence of more rapidly sedimenting cells for a maximum response to the tested mitogens. The purified tonsillar lymphoyctes were 47.0% lymphocytes that have detectable surface immunoglobulin and 29.9% lumphocytes that form rosettes with sheep red blood cells. The predominant cell surface immunoglobulin was IgM. Digestion of the tonsil with trypsin yielded tenfold more plasma cells, more vialbe cells, and a larger proportion of blasts, histiocytes, and binucleated cells than were obtained by mechanical dissociation of the tissue.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1083675      PMCID: PMC2032325     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  33 in total

1.  THE THYMUS; CURRENT CONCEPTS.

Authors:  R A GOOD; R D PETERSON; A E GABRIELSEN
Journal:  Postgrad Med       Date:  1964-11       Impact factor: 3.840

2.  A report on some observations with a simplified cytotoxic test.

Authors:  E A BOYSE; L J OLD; G THOMAS
Journal:  Plast Reconstr Surg       Date:  1962-04       Impact factor: 4.730

3.  Peyer's patch lymphocytes: demonstration of the integrity of afferent and efferent T-cell functions in the guinea pig and rat.

Authors:  D M Levin; D L Rosenstreich; S M Wahl; H Y Reynolds
Journal:  J Immunol       Date:  1974-12       Impact factor: 5.422

4.  Letter: Subpopulations of B lymphocytes in human tonsils and peripheral blood.

Authors:  I Siegel; M H Grieco; S Gupta
Journal:  Lancet       Date:  1974-07-27       Impact factor: 79.321

5.  Agammaglobulinaemia with B lymphocytes. Specific defect of plasma-cell differentiation.

Authors:  M D Cooper; A R Lawton; D E Bockman
Journal:  Lancet       Date:  1971-10-09       Impact factor: 79.321

6.  Dissociation of responses to phytohaemagglutinin and adult allogeneic lymphocytes in human foetal lymphoid tissues.

Authors:  M C Carr; D P Stites; H H Fudenberg
Journal:  Nat New Biol       Date:  1973-02-28

7.  Immunological function of human tonsils, with special reference to E- and EAC-binding lymphocytes.

Authors:  T Tabata; T Enomoto; N Fujimura; K Hiramatsu
Journal:  Acta Otolaryngol       Date:  1974 Jan-Feb       Impact factor: 1.494

8.  A series of compounds active against cestodes.

Authors:  R Baltzly; R B Burrows; M Harfenist; K A Fuller; J E Keeling; O D Standen; C J Hatton; V J Nunns; D A Rawes; B D Blood; V Moya; J L Lelijveld
Journal:  Nature       Date:  1965-04-24       Impact factor: 49.962

9.  Surface bound immunoglobulins as a cell marker in human lymphoproliferative diseases.

Authors:  J L Preud'homme; M Seligmann
Journal:  Blood       Date:  1972-12       Impact factor: 22.113

10.  Identification of a novel cell type in peripheral lymphoid organs of mice. 3. Functional properties in vivo.

Authors:  R M Steinman; D S Lustig; Z A Cohn
Journal:  J Exp Med       Date:  1974-06-01       Impact factor: 14.307

View more
  10 in total

1.  Gut mucosal lymphocytes in inflammatory bowel disease: isolation and preliminary functional characterization.

Authors:  C Fiocchi; J R Battisto; R G Farmer
Journal:  Dig Dis Sci       Date:  1979-09       Impact factor: 3.199

2.  Study of human T and B lymphocytes with heterologous antisera. IV. Subpopulations in tonsil and adenoid cell suspensions.

Authors:  J Brochier; C Samarut; L T Bich-Thuy; J P Revillard
Journal:  Immunology       Date:  1978-11       Impact factor: 7.397

3.  Study of human T and B lymphocytes with heterologous antisera. III. Immunofluorescence studies on tonsil sections.

Authors:  J P Lamelin; N Thomasset; C Andre; J Brochier; J P Revillard
Journal:  Immunology       Date:  1978-09       Impact factor: 7.397

4.  Immunoglobulin systems of human tonsils. I. Control subjects of various ages: quantification of Ig-producing cells, tonsillar morphometry and serum Ig concentrations.

Authors:  P Brandtzaeg; L Surjan; P Berdal
Journal:  Clin Exp Immunol       Date:  1978-03       Impact factor: 4.330

5.  The separation of human palatine tonsillar cells in the reorienting gradient zonal rotor: a large-capacity enrichment of plasma cells.

Authors:  D F Daugherty; J A Scott; T G Pretlow
Journal:  Clin Exp Immunol       Date:  1980-11       Impact factor: 4.330

6.  Sjögren's syndrome in systemic lupus erythematosus and rheumatoid arthritis: immune effector cells in salivary glands.

Authors:  M Malmström; A Seppä; Y T Konttinen; T Helve; S Reitamo
Journal:  Rheumatol Int       Date:  1983       Impact factor: 2.631

7.  Cell fractionation and cytological analysis of human lymphatic cells from tonsil and blood.

Authors:  G Siegel
Journal:  Arch Otorhinolaryngol       Date:  1978-08-31

8.  Immunohistochemical identification of T- and B-lymphocytes delineated by the unlabelled antibody enzyme method. III. Topographical and quantitative distribution of T- and B-cells in human palatine tonsils.

Authors:  G Hoffmann-Fezer; U Löhrs; H V Rodt; S Thierfelder
Journal:  Cell Tissue Res       Date:  1981       Impact factor: 5.249

9.  RON receptor tyrosine kinase, a negative regulator of inflammation, is decreased during simian immunodeficiency virus-associated central nervous system disease.

Authors:  Daniele C Cary; Janice E Clements; Andrew J Henderson
Journal:  J Immunol       Date:  2013-09-16       Impact factor: 5.422

10.  Disaggregation of human solid tumours by combined mechanical and enzymatic methods.

Authors:  S A Engelholm; M Spang-Thomsen; N Brünner; I Nøhr; L L Vindeløv
Journal:  Br J Cancer       Date:  1985-01       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.